Hofseth Biocare (Norway) Probability of Future Stock Price Finishing Over 1.24
| HBC Stock | NOK 1.25 0.01 0.79% |
Hofseth |
Hofseth Biocare Target Price Odds to finish over 1.24
The tendency of Hofseth Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 1.24 in 90 days |
| 1.25 | 90 days | 1.24 | about 91.92 |
Based on a normal probability distribution, the odds of Hofseth Biocare to stay above 1.24 in 90 days from now is about 91.92 (This Hofseth Biocare ASA probability density function shows the probability of Hofseth Stock to fall within a particular range of prices over 90 days) . Probability of Hofseth Biocare ASA price to stay between 1.24 and its current price of 1.25 at the end of the 90-day period is near 1 .
Assuming the 90 days trading horizon Hofseth Biocare ASA has a beta of -0.49. This usually indicates as returns on the benchmark increase, returns on holding Hofseth Biocare are expected to decrease at a much lower rate. During a bear market, however, Hofseth Biocare ASA is likely to outperform the market. Additionally Hofseth Biocare ASA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Hofseth Biocare Price Density |
| Price |
Predictive Modules for Hofseth Biocare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hofseth Biocare ASA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hofseth Biocare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hofseth Biocare is not an exception. The market had few large corrections towards the Hofseth Biocare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hofseth Biocare ASA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hofseth Biocare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.62 | |
β | Beta against Dow Jones | -0.49 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.19 |
Hofseth Biocare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hofseth Biocare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hofseth Biocare ASA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hofseth Biocare ASA generated a negative expected return over the last 90 days | |
| Hofseth Biocare ASA may become a speculative penny stock | |
| Hofseth Biocare ASA has high historical volatility and very poor performance | |
| Hofseth Biocare ASA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 87.62 M. Net Loss for the year was (126.46 M) with profit before overhead, payroll, taxes, and interest of 28.51 M. | |
| Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 53.0% of the company shares are held by company insiders |
Hofseth Biocare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hofseth Stock often depends not only on the future outlook of the current and potential Hofseth Biocare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hofseth Biocare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 357.8 M | |
| Cash And Short Term Investments | 47.2 M |
Hofseth Biocare Technical Analysis
Hofseth Biocare's future price can be derived by breaking down and analyzing its technical indicators over time. Hofseth Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hofseth Biocare ASA. In general, you should focus on analyzing Hofseth Stock price patterns and their correlations with different microeconomic environments and drivers.
Hofseth Biocare Predictive Forecast Models
Hofseth Biocare's time-series forecasting models is one of many Hofseth Biocare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hofseth Biocare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Hofseth Biocare ASA
Checking the ongoing alerts about Hofseth Biocare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hofseth Biocare ASA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hofseth Biocare ASA generated a negative expected return over the last 90 days | |
| Hofseth Biocare ASA may become a speculative penny stock | |
| Hofseth Biocare ASA has high historical volatility and very poor performance | |
| Hofseth Biocare ASA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 87.62 M. Net Loss for the year was (126.46 M) with profit before overhead, payroll, taxes, and interest of 28.51 M. | |
| Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 53.0% of the company shares are held by company insiders |
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.